Form 4: Sonoma Pharmaceuticals Controller John Dal Poggetto Reports Acquisition and Disposal of Restricted Stock Units

John Dal Poggetto, Controller of Sonoma Pharmaceuticals, reports the acquisition of 7,500 Restricted Stock Units (RSUs) and disposal of 10,250 RSUs on January 2, 2025, according to a Form 4 filing.

Summary

• On January 2, 2025, John Dal Poggetto, Controller of Sonoma Pharmaceuticals, filed a Form 4.
• The filing reports the acquisition of 7,500 Restricted Stock Units (RSUs) and disposal of 10,250 RSUs.
• The RSUs vest one-third each on July 2, 2025, July 2, 2026 and January 2, 2027, or upon change of control.
• The RSUs were awarded for services performed as part of the Company's annual equity grant.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, so the sentiment is neutral.

Future Outlook

The vesting schedule of the RSUs provides a future incentive for the reporting person.

Management Comments

• The RSUs were awarded and granted to Mr. Dal Poggetto for services performed as part of the Company's annual equity grant.

Industry Context

Form 4 filings are a standard part of regulatory compliance for company insiders, providing transparency into their transactions in the company's securities.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.

Key Dates

Keywords

Form 4, SNOA, Sonoma Pharmaceuticals, Restricted Stock Units, RSU, Dal Poggetto, Equity Grant, Controller, Beneficial Ownership